What is Grove Labs?
Grove Labs operates within the Medical Laboratories & Imaging Centers industry, a field critical for diagnostic and therapeutic advancements. The company, headquartered in Somerville, Massachusetts, employs between 20 to 49 individuals and generates between $5 million to $10 million in revenue. This positions Grove Labs as a developing entity poised for scaling, likely leveraging its recent enterprise-level funding to expand its operational capacity and technological offerings.
How much funding has Grove Labs raised?
Grove Labs has raised a total of $4M across 2 funding rounds:
Angel/Seed
$2.2M
Private Equity
$1.8M
Angel/Seed (2014): $2.2M with participation from Felicis Ventures and Upfront Ventures
Private Equity (2015): $1.8M, investors not publicly disclosed
Key Investors in Grove Labs
Felicis Ventures
Felicis Ventures is a Menlo Park-based venture capital firm that raises multistage funds to invest in early and growth-stage technology companies across sectors such as SaaS, AI, fintech, and consumer, typically leading seed and Series A rounds and supporting founders through scaleup and exit.
Upfront Ventures
Upfront Ventures is a venture capital firm located in Los Angeles that focuses on investing in technology businesses. Their investment areas include digital media, SaaS, consumer internet, and retail innovation. The firm aims to support startups and emerging companies within these sectors.
What's next for Grove Labs?
The substantial enterprise-level funding indicates Grove Labs is likely entering a phase of significant expansion and market penetration. This capital infusion is expected to fuel research and development, enhance imaging technologies, and potentially broaden the company's service reach. Strategic investments of this magnitude often signal a move towards scaling operations, solidifying market position, and preparing for future growth phases, possibly including further funding rounds or strategic partnerships.
See full Grove Labs company page
